Future studies will focus on exploring the applicability of using Nr1d1 gene delivery for treating Nr2e3-associated retinal degeneration at advanced stages of disease, as well as retinal disease with other genetic causes. Here, NR2E3 is linked to Abnormal retinal morphology.